AU2013308992B2 - Chlorhexidine gluconate solubilized in a hydrophobic monoacylglyceride - Google Patents
Chlorhexidine gluconate solubilized in a hydrophobic monoacylglyceride Download PDFInfo
- Publication number
- AU2013308992B2 AU2013308992B2 AU2013308992A AU2013308992A AU2013308992B2 AU 2013308992 B2 AU2013308992 B2 AU 2013308992B2 AU 2013308992 A AU2013308992 A AU 2013308992A AU 2013308992 A AU2013308992 A AU 2013308992A AU 2013308992 B2 AU2013308992 B2 AU 2013308992B2
- Authority
- AU
- Australia
- Prior art keywords
- monoacylglyceride
- weight
- composition
- chlorhexidine gluconate
- chg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000002209 hydrophobic effect Effects 0.000 title claims abstract description 36
- 229960003333 chlorhexidine gluconate Drugs 0.000 title claims abstract description 19
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 230000027455 binding Effects 0.000 claims description 14
- 125000002252 acyl group Chemical group 0.000 claims description 10
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 claims description 6
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 4
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 claims description 3
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 claims description 3
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims description 3
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 claims description 3
- 239000013008 thixotropic agent Substances 0.000 claims description 3
- 125000003892 C18 acyl group Chemical group 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 9
- KUXUALPOSMRJSW-IFWQJVLJSA-N 2-[6-[[amino-[[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 KUXUALPOSMRJSW-IFWQJVLJSA-N 0.000 description 44
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000004088 simulation Methods 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 125000005647 linker group Chemical group 0.000 description 4
- 238000000329 molecular dynamics simulation Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 125000004185 ester group Chemical group 0.000 description 3
- 239000012457 nonaqueous media Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000353097 Molva molva Species 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012900 molecular simulation Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008866 synergistic binding Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261694080P | 2012-08-28 | 2012-08-28 | |
| US61/694,080 | 2012-08-28 | ||
| PCT/US2013/056802 WO2014035971A2 (en) | 2012-08-28 | 2013-08-27 | Chlorhexidine gluconate solubilized in a hydrophobic monoacylglyceride |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2013308992A1 AU2013308992A1 (en) | 2015-03-12 |
| AU2013308992B2 true AU2013308992B2 (en) | 2016-06-23 |
Family
ID=49151333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013308992A Ceased AU2013308992B2 (en) | 2012-08-28 | 2013-08-27 | Chlorhexidine gluconate solubilized in a hydrophobic monoacylglyceride |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20150238444A1 (enExample) |
| EP (1) | EP2890362B1 (enExample) |
| JP (1) | JP6158928B2 (enExample) |
| CN (1) | CN104684536B (enExample) |
| AU (1) | AU2013308992B2 (enExample) |
| BR (1) | BR112015004178A2 (enExample) |
| CA (1) | CA2882964A1 (enExample) |
| MX (1) | MX367220B (enExample) |
| WO (1) | WO2014035971A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2373270B8 (en) | 2009-01-07 | 2023-04-12 | entrotech life sciences, inc. | Chlorhexidine-containing antimicrobial laminates |
| BR112015004600A2 (pt) | 2012-08-28 | 2017-07-04 | 3M Innovative Properties Co | composições de gluconato de clorexidina, sistemas e artigos de resina |
| US11039615B2 (en) | 2014-04-18 | 2021-06-22 | Entrotech Life Sciences, Inc. | Methods of processing chlorhexidine-containing polymerizable compositions and antimicrobial articles formed thereby |
| WO2017160785A1 (en) | 2016-03-18 | 2017-09-21 | 3M Innovative Properties Company | Adhesive compositions with (meth) acrylic-based block copolymers |
| WO2020109934A1 (en) * | 2018-11-30 | 2020-06-04 | 3M Innovative Properties Company | Topical antimicrobial microemulsions with fluorescent materials |
| WO2021019339A1 (en) | 2019-08-01 | 2021-02-04 | 3M Innovative Properties Company | An antimicrobial device for an insertion needle |
| US12179472B2 (en) | 2019-11-04 | 2024-12-31 | Solventum Intellectual Properties Company | Reinforced adhesive substrate |
| EP4061901A1 (en) | 2019-11-20 | 2022-09-28 | 3M Innovative Properties Company | Medical tapes with high optical clarity when over-taped |
| EP4259737A1 (en) | 2020-12-11 | 2023-10-18 | 3M Innovative Properties Company | Perforated tapes for medical applications |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0399010A (ja) * | 1989-09-13 | 1991-04-24 | Taisho Pharmaceut Co Ltd | 医薬組成物 |
| US5017617A (en) * | 1988-11-22 | 1991-05-21 | Saraya Kabushiki Kaisha | Disinfectant composition for medical use |
| US20080064711A1 (en) * | 2002-11-21 | 2008-03-13 | J.P.M.E.D. Ltd. | Composition for treating oral cavity and Mucousal infections |
| US20100022654A1 (en) * | 2006-10-27 | 2010-01-28 | Asmus Robert A | Antimicrobial compositions |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1599159A (en) * | 1977-02-08 | 1981-09-30 | Roussel Lab Ltd | Pharmaceutical compositions containing chlorhexidine |
| US5093109A (en) * | 1990-04-04 | 1992-03-03 | Chanel, Inc. | Cosmetic composition |
| US6458341B1 (en) * | 1998-06-04 | 2002-10-01 | 3M Innovative Properties Company | Devices with coatings containing chlorhexidine gluconate, compositions and methods |
| US20030031694A1 (en) * | 2001-04-20 | 2003-02-13 | 3M Innovative Properties Company | Controlled release particles |
| DE20204160U1 (de) * | 2002-03-14 | 2002-07-04 | Köhler Pharma GmbH, 64665 Alsbach-Hähnlein | Hauptpflegemittel |
| US20050245738A1 (en) * | 2004-05-03 | 2005-11-03 | Lupin Ltd | Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof |
| US20050271611A1 (en) * | 2004-06-08 | 2005-12-08 | Shiseido Co., Ltd. | Cosmetic |
| US20060205838A1 (en) * | 2005-03-10 | 2006-09-14 | Velamakanni Bhaskar V | Hardenable antimicrobial dental compositions and methods |
| JP2007217394A (ja) * | 2006-02-16 | 2007-08-30 | I-Nage:Kk | 医薬組成物 |
-
2013
- 2013-08-27 CA CA2882964A patent/CA2882964A1/en not_active Abandoned
- 2013-08-27 MX MX2015002542A patent/MX367220B/es active IP Right Grant
- 2013-08-27 AU AU2013308992A patent/AU2013308992B2/en not_active Ceased
- 2013-08-27 JP JP2015529929A patent/JP6158928B2/ja not_active Expired - Fee Related
- 2013-08-27 CN CN201380045403.1A patent/CN104684536B/zh not_active Expired - Fee Related
- 2013-08-27 US US14/424,198 patent/US20150238444A1/en not_active Abandoned
- 2013-08-27 WO PCT/US2013/056802 patent/WO2014035971A2/en not_active Ceased
- 2013-08-27 EP EP13759935.3A patent/EP2890362B1/en not_active Not-in-force
- 2013-08-27 BR BR112015004178A patent/BR112015004178A2/pt active Search and Examination
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5017617A (en) * | 1988-11-22 | 1991-05-21 | Saraya Kabushiki Kaisha | Disinfectant composition for medical use |
| JPH0399010A (ja) * | 1989-09-13 | 1991-04-24 | Taisho Pharmaceut Co Ltd | 医薬組成物 |
| US20080064711A1 (en) * | 2002-11-21 | 2008-03-13 | J.P.M.E.D. Ltd. | Composition for treating oral cavity and Mucousal infections |
| US20100022654A1 (en) * | 2006-10-27 | 2010-01-28 | Asmus Robert A | Antimicrobial compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2015002542A (es) | 2015-06-23 |
| MX367220B (es) | 2019-08-09 |
| JP2015526518A (ja) | 2015-09-10 |
| BR112015004178A2 (pt) | 2017-07-04 |
| EP2890362A2 (en) | 2015-07-08 |
| EP2890362B1 (en) | 2020-11-11 |
| WO2014035971A2 (en) | 2014-03-06 |
| CN104684536B (zh) | 2018-01-12 |
| US20150238444A1 (en) | 2015-08-27 |
| JP6158928B2 (ja) | 2017-07-05 |
| WO2014035971A3 (en) | 2014-10-30 |
| CA2882964A1 (en) | 2014-03-06 |
| CN104684536A (zh) | 2015-06-03 |
| AU2013308992A1 (en) | 2015-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2013308992B2 (en) | Chlorhexidine gluconate solubilized in a hydrophobic monoacylglyceride | |
| EP3100715B1 (en) | Cosmetic composition | |
| JP2015506978A (ja) | ヘルスケア有効成分の送達用シリコーンエマルション | |
| EP4130013A1 (en) | Ionic liquid, solvent, preparation, and transdermally absorbable agent | |
| US8569218B2 (en) | Cleaning composition containing polymer microemulsion | |
| JP2016534028A (ja) | 分枝状の起泡性界面活性剤を含有する発泡性のアルコール組成物 | |
| WO2018182003A1 (ja) | ヒアルロン酸複合ナノ粒子 | |
| EP1756226B1 (en) | Silicone vesicles | |
| EP2514405B1 (en) | Silicone Microemulsion Composition | |
| US5582813A (en) | Iodine-containing fluorocarbon contrast agents | |
| JPH11500413A (ja) | 有機酸のｎ−アルキル−ｎ−ヒドロキシルアミドの常磁性錯体及びそれを含有する磁気共鳴影像（ｍｒｉ）のためのエマルジョン | |
| JP5865623B2 (ja) | 皮膚外用剤およびその製造方法 | |
| JP2003146872A (ja) | 脂質分散組成物及びこれを含有する皮膚外用剤 | |
| JP6527347B2 (ja) | 透明ないし半透明の化粧料 | |
| JP2008024681A (ja) | ベシクル含有組成物及びその製造方法 | |
| CN110037050B (zh) | 一种高效复合碘溶液及其制备方法 | |
| KR20170117771A (ko) | 페녹시에탄올을 포함하는 화장료 조성물 | |
| JPH01175905A (ja) | イソチアゾロン含有非医療用殺菌水性製剤 | |
| EP2066301B1 (en) | Injectable pharmaceutical nimesulide solutions | |
| KR101803976B1 (ko) | 나노에멀젼 형태를 갖는 다목적용 세정제 조성물 | |
| JP6001902B2 (ja) | アスコルビン酸誘導体が配合された組成物 | |
| JP2008266324A (ja) | リポソーム組成物及び該リポソーム組成物を含有した皮膚外用剤 | |
| JP2014141431A (ja) | 皮膚外用剤 | |
| US20090171012A1 (en) | Silicone Vesicles | |
| JP2640675B2 (ja) | エマルジョン組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |